Contact this trialFirst, we need to learn more about you.
Tyrosine Kinase Inhibitor
Asciminib for Chronic Myeloid Leukemia
Recruiting2 awardsPhase 3
Ann Arbor, Michigan
This trial will test the effectiveness of a new drug, asciminib, for treating chronic myeloid leukemia (CML). The trial will enroll patients who have previously been treated with other drugs for CML, and who either do or do not have a specific mutation (T315I).
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service